Siltuximab In Siltuximab-RElapsed/REfractory Multicentric CAstleman Disease
Clinical trial NCT04838860 · TERMINATED
Trial details
- NCT number
- NCT04838860
- Sponsor
- RECORDATI GROUP
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-31
- Primary completion
- 2021-04-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.